Vanguard Group Inc cut its stake in Portola Pharmaceuticals Inc (NASDAQ:PTLA) by 0.9% during the 3rd quarter, according to its most recent Form 13F filing ...
Thromboelastography TEG Analyzer Liver Transplant Cardiac Surgery India TEG 5000 TEMA ROTEM MONOTEMA Platelet Mapping Thromboelastograph www.thromboelastography.com Thromboelastogram Hemostasis Management
Sunday, 13 January 2019
Portola Pharmaceuticals Inc (PTLA) Position Cut by Vanguard Group Inc - Fairfield Current
Portola Pharmaceuticals Inc (PTLA) Position Cut by Vanguard Group Inc Fairfield Current
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment